STRIDES PHARMA SCIENCE
Back to Income Statement
|
STRIDES PHARMA SCIENCE Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹-71 Cr | ₹-203 Cr | ₹-460 Cr | ₹268 Cr | ₹36 Cr |
What is the latest Consolidated Net Profit of STRIDES PHARMA SCIENCE ?
Year | Consolidated Net Profit |
---|---|
Mar2024 | ₹-71 Cr |
Mar2023 | ₹-203 Cr |
Mar2022 | ₹-460 Cr |
Mar2021 | ₹268 Cr |
Mar2020 | ₹36 Cr |
How is Consolidated Net Profit of STRIDES PHARMA SCIENCE Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2024 | ₹-71 Cr | Negative | |
Mar2023 | ₹-203 Cr | Negative | |
Mar2022 | ₹-460 Cr | Negative | |
Mar2021 | ₹268 Cr | 637.66 | |
Mar2020 | ₹36 Cr | - |
Compare Consolidated Net Profit of peers of STRIDES PHARMA SCIENCE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
STRIDES PHARMA SCIENCE | ₹6,018.4 Cr | 11.8% | 11.4% | -20.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹420,136.0 Cr | 6% | 4% | 9.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹149,680.0 Cr | 4.7% | 0.3% | 52.4% | Stock Analytics | |
CIPLA | ₹122,394.0 Cr | 7% | 3.7% | 7.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹110,159.0 Cr | 4.1% | 6.4% | 25% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,105.6 Cr | 6.3% | 5% | -4.7% | Stock Analytics |
STRIDES PHARMA SCIENCE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
STRIDES PHARMA SCIENCE | 11.8% |
11.4% |
-20.8% |
SENSEX | 5.8% |
6.1% |
4.7% |
You may also like the below Video Courses